Wajd N Al-Holou, MD
Assistant Professor of Neurosurgery and Co-Director
CNS Tumor Registry
Neurosurgery
1500 E. Medical Center Drive, 3470 Taubman Center
Ann Arbor, MI 48109-5338
[email protected]

Available to mentor
Wajd N Al-Holou, MD
Assistant Professor
  • Qualifications
  • Recent Publications
    • Qualifications
    • Clinical Fellow
      University of Texas, MD Anderson Cancer Center, Neurosurgical Oncology, 2017
    • Residency
      University of Michigan, Neurosurgery, 2016
    • Chief Resident
      University of Michigan, Neurosurgery, 2016
    • MD
      University of Michigan, Ann Arbor, 2009
    • BS
      University of Detroit Mercy, Detroit, 2003
    Recent Publications See All Publications
    • Proceeding / Abstract / Poster
      Abstract LB013: Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma
      Al-Holou WN, Wang H, Ravikumar V, Oneka M, Verhaak RG, Kim H, Pratt D, Camelo-Piragua S, Speers C, Wahl D, Shankar S, Hollon T, Sagher O, Heth J, Muraszko KM, Lawrence TS, deCarvalho AC, Mikkelsen T, Rao A, Rehemtulla A. Cancer Research, 2022 Jun 15; 82 (12_Supplement): lb013 - lb013. DOI:10.1158/1538-7445.am2022-lb013
    • Proceeding / Abstract / Poster
      The prevalence and natural history of pineal cysts in adults
      Terman S, Al-Holou WN, Kilburg C, Garton HJL, Maher CO. 2011 Apr 4;
    • Journal Article
      CTNI-19. MYCOPHENOLATE MOFETIL TARGETS GLIOBLASTOMA DE-NOVO PURINE METABOLISM TO OVERCOME CHEMORADIATION RESISTANCE IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
      Umemura Y, Clarke N, Al-Holou W, Elaimy A, Scott A, Leung D, Kim M, Ferris S, Thomas J, Heth J, Schipper M, Suresh K, Lawrence T, Wahl D. Neuro-Oncology, 2024 Nov 11; 26 (Supplement_8): viii99 - viii100. DOI:10.1093/neuonc/noae165.0386
    • Journal Article
      DNAR-08. THY1 MEDIATES TREATMENT RESISTANCE IN GLIOBLASTOMA THROUGH RAPID REPAIR OF DNA DAMAGE
      Syed SB, Tripathy A, Ravikumar V, Awadia S, Palavalasa S, Huang D-L, Rao A, Wahl DR, Rehemtulla A, Al-Holou WN. Neuro-Oncology, 2024 Nov 11; 26 (Supplement_8): viii118 - viii119. DOI:10.1093/neuonc/noae165.0459
    • Journal Article
      NCOG-47. DEFINING PERIOPERATIVE RISK FACTORS IN STEREOTACTIC BRAIN BIOPSIES AMONG DIFFERENT HISTOLOGIC DIAGNOSES
      Tripathy A, Harake E, Saleh S, Al-Holou W. Neuro-Oncology, 2024 Nov 11; 26 (Supplement_8): viii235 - viii235. DOI:10.1093/neuonc/noae165.0928
    • Journal Article
      PATH-58. SEQUENCING OF DNA RECOVERED FROM BRAIN TUMOR BIOPSY SURGICAL WASTE IMPROVES SENSITIVITY OF RAPID IDH/TP53-MUTANT TUMOR DIAGNOSES
      Wadden J, Adam T, Cartaxo R, Niculcea M, Kong S, John V, Tripathy A, Bird C, Nazarian J, Heth J, Muraszko K, Marupudi N, Magge S, Garton H, Al-Holou W, Koschmann C. Neuro-Oncology, 2024 Nov 11; 26 (Supplement_8): viii192 - viii192. DOI:10.1093/neuonc/noae165.0757
    • Journal Article
      TMET-19. REWIRING OF CORTICAL GLUCOSE METABOLISM FUELS HUMAN BRAIN CANCER GROWTH
      Scott A, Mittal A, Meghdadi B, Palavalasa S, Achreja A, O’Brien A, Kothari A, Zhou W, Xu J, Lin A, Wilder-Romans K, Edwards D, Wu Z, Feng J, Andren A, Zhang L, Tarnal V, Redic K, Qi N, Fischer J, Yang E, Regan M, Stopka S, Baquer G, Lawrence T, Venneti S, Agar N, Lyssiotis C, Al-Holou W, Nagrath D, Wahl D. Neuro-Oncology, 2024 Nov 11; 26 (Supplement_8): viii291 - viii292. DOI:10.1093/neuonc/noae165.1157
    • Journal Article
      TMET-27. MACHINE LEARNING-BASED IDENTIFICATION OF METABOLIC FLUXES IN PATIENT BRAIN TUMORS
      Meghdadi B, Mittal A, Scott A, Liang N, Palavalasa S, Achreja A, Kothari AOA, Zhou W, Xu J, Lin A, Wilder-Romans K, Edwards D, Wu Z, Feng J, Andren A, Zhang L, Tarnal V, Redic K, Qi N, Lawrence T, Lyssiotis C, Al-Holou W, Wahl D, Nagrath D. Neuro-Oncology, 2024 Nov 11; 26 (Supplement_8): viii294 - viii294. DOI:10.1093/neuonc/noae165.1165